ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,785Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 663

$659K Total Retail Price of All Prescriptions

Rank: 30 out of 663

388 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

26% of this provider’s 388 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

16% of this provider’s 388 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 8,874 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LEVOTHYROXINE SODIUM 508 472 1 3
WARFARIN SODIUM 449 327 2 8
FUROSEMIDE 415 349 3 7
LISINOPRIL 368 300 4 2
CITALOPRAM HBR 319 236 5 18
HYDROCODONE-ACETAMINOPHEN 291 218 S3 6 6
DONEPEZIL HCL 286 266 7 40
OMEPRAZOLE 282 187 8 4
SIMVASTATIN 274 225 9 1
AMLODIPINE BESYLATE 266 222 10 5
NAMENDA 211 211 11 57
OXYCODONE HCL 195 106 S2 12 41
ZOLPIDEM TARTRATE 193 103 13 16
GABAPENTIN 190 103 14 20
POTASSIUM CHLORIDE 177 154 15 23
OXYCODONE-ACETAMINOPHEN 170 79 S2 16 26
METFORMIN HCL 169 142 17 9
METOPROLOL TARTRATE 167 121 18 11
MORPHINE SULFATE ER 158 67 S2 19 51
METOPROLOL SUCCINATE 147 137 20 25
KLOR-CON M20 142 114 21 70
ATENOLOL 136 130 22 10
LEVOFLOXACIN 133 117 23 92
BACLOFEN 114 33 24 122
ATORVASTATIN CALCIUM 113 104 25 13
HYDROCHLOROTHIAZIDE 104 76 26 12
LANTUS 99 90 27 48
POLYETHYLENE GLYCOL 3350 99 76 27 82
PREDNISONE 97 78 29 39
ESCITALOPRAM OXALATE 92 81 30 77
MIRTAZAPINE 90 89 31 52
JANUVIA 89 88 32 78
VENLAFAXINE HCL ER 87 56 33 86
FENTANYL 83 61 S2 34 75
TAMSULOSIN HCL 80 61 35 24
OLANZAPINE 79 70 36 88
TRAZODONE HCL 79 40 36 34
PROAIR HFA 77 63 38 33
LIDODERM 76 55 39 67
GLIPIZIDE ER 75 68 40 130
EXELON 75 62 40 172
LYRICA 73 67 42 96
TRAMADOL HCL 72 52 43 17
ADVAIR DISKUS 67 50 44 53
FLUTICASONE PROPIONATE 66 41 45 27
CARVEDILOL 60 58 46 47
CYMBALTA 58 48 47 54
KLOR-CON M10 58 42 47 139
LEXAPRO 56 42 49 197
PANTOPRAZOLE SODIUM 51 39 50 45
SPIRIVA 50 36 51 62
DIVALPROEX SODIUM 50 40 51 81
SERTRALINE HCL 50 34 51 35
FAMOTIDINE 50 47 51 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 30, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.